D R Gandara Selected Research

Palliative Care (Palliative Therapy)

7/2000

Gemcitabine/carboplatin combination regimens: importance of dose schedule.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D R Gandara Research Topics

Disease

15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2000
10	Neoplasms (Cancer) 05/2015 - 08/2000
2	Lung Neoplasms (Lung Cancer) 05/2015 - 09/2007
2	Neutropenia 12/2014 - 07/2001
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2001 - 08/2001
2	Thrombocytopenia (Thrombopenia) 07/2001 - 03/2001
2	Neoplasm Metastasis (Metastasis) 06/2001 - 07/2000
2	Neoplasm Micrometastasis 06/2001 - 07/2000
1	Disease Progression 01/2019
1	Leiomyosarcoma 05/2015
1	Sarcoma (Soft Tissue Sarcoma) 05/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2015
1	Carcinogenesis 02/2014
1	Colorectal Neoplasms (Colorectal Cancer) 02/2014
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 07/2005
1	Death (Near-Death Experience) 07/2001
1	Carcinoma (Carcinomatosis) 07/2001
1	Melanoma (Melanoma, Malignant) 01/2001
1	Adenocarcinoma 08/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2000
1	Nausea 01/2000
1	Vomiting 01/2000

Drug/Important Bio-Agent (IBA)

9	Cisplatin (Platino)FDA LinkGeneric 12/2014 - 01/2000
5	Paclitaxel (Taxol)FDA LinkGeneric 07/2005 - 03/2001
4	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2000
4	PlatinumIBA 07/2001 - 01/2000
3	Etoposide (VP 16)FDA LinkGeneric 08/2001 - 08/2000
3	Gemcitabine FDA Link 07/2001 - 07/2000
3	Carboplatin (JM8)FDA LinkGeneric 07/2001 - 03/2001
2	atezolizumabIBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 05/2015 - 04/2007
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2001 - 08/2000
2	Radiation-Sensitizing AgentsIBA 06/2001 - 07/2000
1	Proton Pump InhibitorsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	B7-H1 AntigenIBA 01/2019
1	temsirolimus FDA Link 05/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2015
1	AZD 6244IBA 05/2015
1	Pharmaceutical PreparationsIBA 05/2015
1	halichondrin BIBA 12/2014
1	eribulin FDA Link 12/2014
1	Monoclonal AntibodiesIBA 02/2014
1	Biological ProductsIBA 02/2014
1	Codon (Codons)IBA 09/2007
1	DNA (Deoxyribonucleic Acid)IBA 09/2007
1	ErbB Receptors (EGF Receptor)IBA 04/2007
1	Gefitinib (Iressa)FDA Link 04/2007
1	Proteins (Proteins, Gene)FDA Link 04/2007
1	Vincristine (Oncovin)FDA LinkGeneric 08/2001
1	Toremifene (Fareston)FDA Link 07/2001
1	Vinorelbine (Navelbine)FDA LinkGeneric 07/2001
1	Estrogen ReceptorsIBA 07/2001
1	Protein Kinase C-epsilonIBA 07/2001
1	Protein Isoforms (Isoforms)IBA 07/2001
1	Isotretinoin (Accutane)FDA LinkGeneric 04/2001
1	RetinoidsIBA 04/2001
1	Fluorouracil (Carac)FDA LinkGeneric 08/2000
1	Leucovorin (Folinic Acid)FDA Link 08/2000
1	Interferon-alpha (Interferon Alfa)IBA 08/2000
1	Antineoplastic Agents (Antineoplastics)IBA 07/2000
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2000
1	Prochlorperazine (Compazine)FDA LinkGeneric 01/2000
1	AntiemeticsIBA 01/2000
1	Granisetron (Kytril)FDA LinkGeneric 01/2000

Therapy/Procedure

11	Therapeutics 05/2015 - 01/2000
8	Drug Therapy (Chemotherapy) 01/2020 - 07/2000
3	Radiotherapy 08/2001 - 07/2000
2	Chemoradiotherapy 06/2001 - 07/2000
1	Transcutaneous Electric Nerve Stimulation (TENS) 05/2015
1	Combination Drug Therapy (Combination Chemotherapy) 07/2001
1	Chemoprevention 04/2001
1	Neoadjuvant Therapy 02/2001
1	Combined Modality Therapy 07/2000
1	Palliative Care (Palliative Therapy) 07/2000